This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: j.jacc.2005.05.067v3 46/6/1036    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Sheppard, R. Search for Related Content PubMed PubMed Citation Articles by Sheppard, R.

CLINICAL RESEARCH: MYOCARDITIS

Myocardial Expression of Fas and Recovery of Left Ventricular Function in Patients With Recent-Onset Cardiomyopathy

Richard Sheppard, MD^_*, Maninder Bedi, MD, Toru Kubota, MD, PhD, Marc J. Semigran, MD, William Dec, MD, Richard Holubkov, PhD^||, Arthur M. Feldman, MD, PhD^¶, Warren D. Rosenblum, MD^#, Charles F. McTiernan, PhD, Dennis M. McNamara, MD^,_* for the IMAC Investigators

^_* McGill University, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Canada
Cardiovascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
Cardiovascular Medicine, Kyushu University, Fukuoka, Japan
Massachusetts General Hospital, Boston, Massachusetts
^|| Department of Family and Preventive Medicine, School of Medicine, University of Utah, Salt Lake City, Utah
^¶ Department of Medicine, Jefferson Medical College, Philadelphia, Pennsylvania
^# New York Medical College, Valhalla, New York

Manuscript received March 4, 2005; revised manuscript received April 27, 2005, accepted May 3, 2005.

^_* Reprint requests and correspondence: Dr. Dennis M. McNamara, Heart Failure/Transplantation Program, Cardiovascular Institute, University of Pittsburgh Medical Center, 566 Scaife Hall, 200 Lothrop Street, Pittsburgh, Pennsylvania 15213 (Email: mcnamaradm{at}upmc.edu).

OBJECTIVES: This study aimed to evaluate the role of gene expression for predicting myocardial recovery in recent-onset cardiomyopathy.

BACKGROUND: Apoptosis may limit ventricular recovery. We examined the myocardial expression of Fas, Fas ligand (FasL), tumor necrosis factor (TNF)-alpha, and TNF receptor 1 (TNFR1), and myocardial recovery in patients from the multicenter Intervention in Myocarditis and Acute Cardiomyopathy (IMAC) study.

METHODS: Endomyocardial biopsy samples were obtained in 20 patients with recent-onset (<6 months) idiopathic dilated cardiomyopathy (left ventricular ejection fraction [LVEF] 0.40). The LVEF was assessed at baseline and at 6 and 12 months by nuclear scans. Myocardial expression was assessed by ribonuclease (RNase) protection, normalized to a constitutively active gene (glyceraldehydes 3-phosphate dehydrogenase [GAPDH]) and reported as percent GAPDH expression. The change in LVEF at 6 and 12 months was compared by tertiles of expression.

RESULTS: For all patients (14 men, 6 women; age 46.5 ± 10.7 years), the mean LVEF was 0.28 ± 0.05 at baseline and 0.40 ± 0.14 at six months. Patients in the highest tertile of Fas expression had minimal improvement at six months (EF = 0.03 ± 0.05) when compared with the intermediate (EF = 0.10 ± 0.13) and lowest tertiles (EF = 0.21 ± 0.11, change in LVEF by tertile, p = 0.006). A similar relationship was seen with TNFR1 expression (highest tertile, EF = 0.06 ± 0.07; lowest tertile, EF = 0.21 ± 0.11, p = 0.02). In contrast with Fas and TNFR1, expression of TNF-alpha and FasL did not predict recovery of LV function.

CONCLUSIONS: In cardiomyopathy of recent onset, increased expression of Fas and TNFR1 was associated with minimal recovery of LV function. Apoptosis limits myocardial recovery, and represents a potential target for therapeutic intervention.

Abbreviations and Acronyms   ACEI = angiotensin-converting enzyme inhibitor   FasL = Fas ligand   FLICE = Fas-associated death domain-like interleukin-1ß-converting enzyme   GAPDH = glyceraldehydes 3-phosphate dehydrogenase   IMAC = Intervention in Myocarditis and Acute Cardiomyopathy study   LVEF = left ventricular ejection fraction   NYHA = New York Heart Association   RNA = ribonucleic acid   TNF = tumor necrosis factor   TNFR = tumor necrosis factor receptor

This article has been cited by other articles:

				J. Zurney, K. E. Howard, and B. Sherry Basal Expression Levels of IFNAR and Jak-STAT Components Are Determinants of Cell-Type-Specific Differences in Cardiac Antiviral Responses J. Virol., December 15, 2007; 81(24): 13668 - 13680. [Abstract] [Full Text] [PDF]

				H. N. Skouri, G. W. Dec, M. G. Friedrich, and L. T. Cooper Noninvasive Imaging in Myocarditis J. Am. Coll. Cardiol., November 21, 2006; 48(10): 2085 - 2093. [Abstract] [Full Text] [PDF]

				F. E. Marchlinski and M. Jessup Timing the Implantation of Implantable Cardioverter-Defibrillators in Patients With Nonischemic Cardiomyopathy J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2483 - 2485. [Full Text] [PDF]

				A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, D. Sahn, and S. Tsimikas Highlights of the Year in JACC 2005 J. Am. Coll. Cardiol., January 3, 2006; 47(1): 184 - 202. [Full Text] [PDF]

				D. L. Mann Determinants of Myocardial Recovery in Myocarditis: Has the Time Come for Molecular Fingerprinting? J. Am. Coll. Cardiol., September 20, 2005; 46(6): 1043 - 1044. [Full Text] [PDF]